Robert G. Canada

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Perussi JR, Paltoo DN, Toppin VAL, et al. (2003) Synergism between dipyridamole and cisplatin in human breast cancer cells in vitro Quimica Nova. 26: 340-343
Fuller TL, Canada RG. (1999) Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells. Cancer Chemotherapy and Pharmacology. 44: 249-52
Canada RG, Paltoo DN. (1998) Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence. Biochimica Et Biophysica Acta. 1448: 85-98
Mack KM, Canada RG, Andrews PA. (1997) The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells. Cancer Chemotherapy and Pharmacology. 39: 217-22
Canada RG, Andrews PA, Mack KM, et al. (1995) The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells. Biochimica Et Biophysica Acta. 1267: 25-30
Canada RG. (1993) Calcium receptor binding of cisplatin and terbium in human breast tumor cells after hyperthermia. Radiation Research. 133: 170-5
Canada RG, Carpentier RG. (1991) Physicochemical characteristics of the terbium-adriamycin complex and its effects on the sinus node automaticity. Biochimica Et Biophysica Acta. 1073: 136-41
Canada RG, Saway W, Thompson E. (1988) Interactions of adriamycin with a calcium binding site. Biochemical and Biophysical Research Communications. 151: 679-85
Canada RG. (1988) Terbium luminescence studies of binding of adriamycin and cisplatin to tumorigenic cells Analytica Chimica Acta. 205: 77-87
Canada RG. (1986) Terbium fluorescence studies of cisplatin binding to GH3/B6 pituitary tumor cells. Biochimica Et Biophysica Acta. 887: 29-34